MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Executive functions"

  • 2018 International Congress

    Frontal-subcortical cognitive impairments in Parkinson’s patients with freezing of gait

    J. Garcia-Caldentey, MA. Prats-Sedano, E. Estelrich-Peyret, PJ. Garcia-Ruiz (Palma de Mallorca, Spain)

    Objective: To evaluate the relationship between frontal-subcortical cognitive dysfunctions and freezing of gait (FOG) in Parkinson's disease (PD). Background: FOG is a complex and multisystem…
  • 2018 International Congress

    Eye Movements during Reading in Parkinson’s Disease: A Pilot Study

    J. Waldthaler, P. Tsitsi, G. Öqvist Seimyr, M. Nilsson Benfatto, P. Svenningsson (Marburg, Germany)

    Objective: To characterize eye movements during reading in patients with moderate stage Parkinson's disease (PD) with respect to medication state and cognitive ability. Background: Many…
  • 2018 International Congress

    Executive dysfunctions and behavioral changes in early drug-naïve patients with Parkinson’s disease

    S. Li, R. Ou, X. Yuan, H. Liu, Y. Bing, Q. Wei, W. Song, B. Cao, Y. Chen, H. Shang (Chengdu, China)

    Objective: This study aims to explore the prevalence and onset age-related difference of executive dysfunctions and behavioral changes in drug-naïve patients with early stage of…
  • 2018 International Congress

    Working memory maintenance and manipulation in Parkinson’s disease: An fMRI study

    K. Giehl, A. Ophey, J. Hammes, S. Rehberg, C. Eggers, T. Lichtenstein, D. Maintz, E. Kalbe, T. van Eimeren (Cologne, Germany)

    Objective: This study aimed to investigate the neural correlates of different working memory (WM) aspects in Parkinson's disease (PD) patients using a newly designed WM…
  • 2018 International Congress

    Neuropsychological and clinical assessment for the differential diagnosis of patients with PDD vs. DLB

    E. Fiorenzato, L. Weis, V. Camparini, F. Pistonesi, R. Schifano, E. Gasparoli, A. Antonini, R. Biundo (Venice, Italy)

    Objective: To explore the role of clinical neuropsychological tools in Parkinson’s disease-dementia (PDD) vs. dementia with Lewy bodies (DLB). First, to define the feasibility of…
  • 2018 International Congress

    Sex Differences in Cognitive Performance in De-Novo Parkinson’s Disease

    S. Banks, E. Bayram, J. Kaylegian, B. Bluett (Las Vegas, NV, USA)

    Objective: To investigate whether sex affects cognition in patients with de-novo Parkinson’s disease (PD). Background: Sex differences in PD are common and may be due…
  • 2017 International Congress

    Emotion regulation and neuropsychological status in psychogenic subtypes.

    B. Scott, A. Strutt, P. Lundberg-Love, A. Schmitt, J. Jankovic, D. Bowers (Gainesville, FL, USA)

    Objective: To determine whether cognitive dysfunction is associated with emotion regulation strategies and psychological distress in two psychogenic movement disorder (PMD) variants: non-epileptic seizures (PNES)…
  • 2017 International Congress

    Decisional capacity for Goals of Care in Parkinson’s Disease with Cognitive Concerns

    M. Abu Snineh, R. Camicioli, J. Miyasaki (Jerusalen, Israel)

    Objective: We sought to assess decisional capacity (DC) for Goals of Care (GOC) using the MacArthur Competence Assessment Tool (MacCAT) for Parkinson’s disease (PD) patients…
  • 2017 International Congress

    Effects of dopaminergic medication on executive function in Parkinson’s disease differs according to the clinical stage

    H. Murakami, M. Kezuka, R. Kon, M. Kawamura, K. Ono (Tokyo, Japan)

    Objective: We examined the effect of dopaminergic medication on executive function in 24 drug-naïve PD patients (de novo group) and in 21 PD patients on…
  • 2017 International Congress

    Development and validation of an alternative version of the Parkinson’s Disease-Cognitive Rating Scale

    R. Fernandez-Bobadilla, S. Martinez-Horta, J. Marin-Lahoz, A. Horta-Barba, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: To develop and validate an alternative form of the PD-CRS (PD-CRS/AF) with the objective of providing a reliable and fully equivalent method of reassessment…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley